Management of Neurostorming
The management of neurostorming requires prompt recognition and aggressive treatment of the underlying causes, including sedation, analgesia, and control of secondary brain insults to reduce morbidity and mortality.
Definition and Recognition
Neurostorming, also known as paroxysmal sympathetic hyperactivity (PSH), is characterized by episodes of:
- Hypertension
- Tachycardia
- Tachypnea
- Hyperthermia
- Diaphoresis
- Posturing
- Increased muscle tone
Initial Management Approach
1. Sedation and Analgesia
- First-line treatment: Continuous sedation rather than bolus administration to prevent hemodynamic instability 1
- Avoid hypotensive sedative agents that could compromise cerebral perfusion
- Options include:
- Propofol
- Midazolam (avoid bolus administration which can cause hypotension)
- Opioid analgesics (continuous infusion preferred over bolus)
2. Control of Secondary Brain Insults
Temperature Management
- Treat hyperthermia aggressively as it exacerbates raised intracranial pressure 1
- Target normothermia
- Use antipyretics and cooling measures
Blood Pressure Management
- Maintain systolic blood pressure >110 mmHg to ensure adequate cerebral perfusion 1
- For hypertensive episodes:
- Increase sedation
- Consider small boluses of labetalol 1
Respiratory Management
- Ensure adequate oxygenation (avoid SaO2 <90%) 1
- Control ventilation with endotracheal intubation and mechanical ventilation
- Monitor end-tidal CO2 to maintain normocapnia 1
3. Intracranial Pressure (ICP) Management
If ICP monitoring is in place and shows elevated pressure:
- Elevate head of bed 20-30 degrees to improve venous drainage 1
- Consider osmotic therapy:
- Mannitol
- Hypertonic saline (10% NaCl has shown efficacy in reducing ICP) 2
- Avoid hypo-osmolar fluids which may worsen cerebral edema 1
4. Specific Pharmacological Interventions for Neurostorming
- Beta-blockers (propranolol) to control tachycardia and hypertension
- Alpha-2 agonists (clonidine) to reduce sympathetic outflow
- GABA-ergic agents (baclofen) for increased muscle tone
- Bromocriptine for severe cases
Advanced Management Options
For refractory cases:
- Consider barbiturate coma if ICP remains elevated despite first-line measures 3
- Evaluate for surgical intervention if appropriate:
Monitoring During Management
- Continuous vital signs monitoring
- ICP monitoring in severe traumatic brain injury cases 1
- Cerebral perfusion pressure calculation (CPP = MAP - ICP)
- Consider transcranial Doppler to assess cerebral blood flow 1
Pitfalls and Caveats
Misdiagnosis: Neurostorming can be confused with seizures, pain, withdrawal, or infection. Ensure proper diagnosis before treatment.
Hypotension risk: Overly aggressive treatment of hypertension can lead to cerebral hypoperfusion. Maintain systolic BP >110 mmHg 1.
Fluid management: Avoid both hypovolemia and excessive fluid administration. Target euvolemia with isotonic fluids 1.
Medication interactions: Be aware of potential interactions between sedatives, analgesics, and other medications used in neurocritical care.
Nursing interventions: Some nursing interventions may transiently increase ICP. Family presence, sedation administration, and repositioning have been associated with lower ICP in some studies 4.
The management of neurostorming requires a multidisciplinary approach in a specialized neurocritical care setting with experienced providers to optimize outcomes and reduce secondary brain injury.